Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Hemophilia Drugs Market - Analysis, Technologies & Forecasts to 2020 - Key Vendors are Baxalta, Bayer & CSL Behring - Research and Markets

Research and Markets
Posted on: 27 Oct 16

Research and Markets has announced the addition of the "Global Hemophilia Drugs Market 2016-2020" report to their offering.

The report forecasts the global hemophilia drugs market to grow at a CAGR of 4.76% during the period 2016-2020.

Hemophilia is an X-linked genetic disorder that results in excessive blood loss during an injury, causing fatigue or even death. The disorder is more common in males and affects roughly 400,000 people globally every year. Hemophilia A is the more common form of this disorder, while hemophilia B is the rare form of hemophilia.

To mitigate this disorder, plasma-derived clotting factors or recombinant clotting factors have been developed and are administered to the affected individual. The therapy is usually done in two ways: short acting therapeutic and long-acting therapeutic.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors:

  • Baxalta
  • Bayer
  • CSL Behring
  • Novo Nordisk
  • Pfizer

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Pipeline portfolio

PART 06: Market landscape

PART 07: Market segmentation by type of disease

PART 08: Market segmentation by type of therapy

PART 09: Market segmentation by type of disease management

PART 10: Geographical segmentation

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape

PART 17: Key vendor analysis

PART 18: Appendix

For more information on this topic, check out the Pharmaceuticals and Healthcare section of the Research and Markets' blog.

For more information about this report visit http://www.researchandmarkets.com/research/6kn3bc/global_hemophilia

View source version on businesswire.com: http://www.businesswire.com/news/home/20161027005650/en/

Business Wire
www.businesswire.com

Last updated on: 27/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.